AKT1 and neoplasm: Furthermore, we found no association between mutational status of additional effectors in the PI3K-signaling pathway (AKT1, PDK1, MTOR) amongst cells in the NCI-60 tumor cell line collection and sensitivity to GDC-0941 (Figs. S1D and S1E).